These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Aguilar-Martinez P, Esculié-Coste C, Bismuth M, Giansily-Blaizot M, Larrey D, Schved JF. Blood Cells Mol Dis; 2001 Aug; 27(1):290-3. PubMed ID: 11358390 [Abstract] [Full Text] [Related]
5. C282Y and H63D mutations of HFE gene in patients with advanced alcoholic liver disease. Ropero Gradilla P, Villegas Martínez A, Fernández Arquero M, García-Agúndez JA, González Fernández FA, Benítez Rodríguez J, Díaz-Rubio M, de la Concha EG, Ladero Quesada JM. Rev Esp Enferm Dig; 2001 Mar; 93(3):156-63. PubMed ID: 11469076 [Abstract] [Full Text] [Related]
6. Differential HFE allele expression in hemochromatosis heterozygotes. Rosmorduc O, Poupon R, Nion I, Wendum D, Feder J, Béréziat G, Hermelin B. Gastroenterology; 2000 Oct; 119(4):1075-86. PubMed ID: 11040194 [Abstract] [Full Text] [Related]
7. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis. Ladero JM, Ropero P, Ortega L, Taxonera C, González FA, López-Alonso G, Briceño O, Rodríguez-Agulló JL, González L, Villegas A, Díaz-Rubio M. Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004 [Abstract] [Full Text] [Related]
8. HFE gene C282Y, H63D and S65C mutations frequency in the Transylvania region, Romania. Trifa AP, Popp RA, Militaru MS, Farcaş MF, Crişan TO, Gana I, Cucuianu A, Pop IV. J Gastrointestin Liver Dis; 2012 Jun; 21(2):177-80. PubMed ID: 22720307 [Abstract] [Full Text] [Related]
11. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D. J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300 [Abstract] [Full Text] [Related]
12. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. de Juan D, Reta A, Castiella A, Pozueta J, Prada A, Cuadrado E. Eur J Hum Genet; 2001 Dec; 9(12):961-4. PubMed ID: 11840200 [Abstract] [Full Text] [Related]
13. Prevalence and clinical significance of HFE gene mutations in patients with iron overload. Brandhagen DJ, Fairbanks VF, Baldus WP, Smith CI, Kruckeberg KE, Schaid DJ, Thibodeau SN. Am J Gastroenterol; 2000 Oct; 95(10):2910-4. PubMed ID: 11051367 [Abstract] [Full Text] [Related]
14. HFE genotype frequencies in consecutive reference laboratory specimens: comparisons among referral sources and association with initial diagnosis. Acton RT, Barton JC. Genet Test; 2001 Oct; 5(4):299-306. PubMed ID: 11960574 [Abstract] [Full Text] [Related]
17. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload. Vercesi E, Cerani P, Rolandi V, Rovati A, Bergamaschi G. Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923 [Abstract] [Full Text] [Related]
18. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Distante S, Berg JP, Lande K, Haug E, Bell H. Gut; 2000 Oct; 47(4):575-9. PubMed ID: 10986220 [Abstract] [Full Text] [Related]